据《雅加达邮报》3月10日报道：国有制药公司法尔马生物准备开发可注射的小儿麻痹症疫苗，来代替目前孩子们必须口服的疫苗。

法尔马生物公司总裁伊斯坎德尔说，印尼疫苗制造商生产的小儿麻痹症疫苗销往全世界132个国家，但是这些全是口服疫苗。周二在西爪哇万隆法尔马生物综合设施举行了关于小儿麻痹症的2016年国家免疫周发布会，他在会后说：“可注射疫苗将代替目前使用的疫苗。”

每年法尔马生物公司生产至少14亿剂小儿麻痹症疫苗来满足全球需求。伊斯坎德尔解释说：“大约两千万剂是用来满足国内需求。”

伊斯坎德尔说，伴随到2020年消除小儿麻痹症的全球目标，法尔马生物已经准备了各种措施，包括准备未激活的小儿麻痹症疫苗（IPV）。

IPV是一种注射剂，可以单独使用，也可以和其他疫苗结合使用。

伊斯坎德尔说：“大约100人参与了这种注射疫苗的生产过程，”他补充道，该公司从1992年开始准备IPV。

2015年5月在瑞士日内瓦举行的第68届世界卫生大会上，小儿麻痹症是讨论的主要议题之一。在会上，卫生部长表达了政府承诺支持消除小儿麻痹症的IPV使用的世界政策。

印尼的免疫计划包括把小儿麻痹症疫苗扩展到0~59个月的儿童，使印尼在2017年3月27日从世界卫生组织获得无小儿麻痹症的证书。

法尔马公司秘书M.Rahman Rustan表示，该公司目前正供应全世界小儿麻痹症疫苗需求的三分之二。

State-owned pharmaceutical company Bio Farma is set to develop injectable polio vaccines, replacing the current vaccines that children must take orally.

Bio Farma president director Iskandar said the Indonesian vaccine manufacturer currently supplied polio vaccines to 132 countries in the world, but all of them were oral vaccines. “The injectable vaccines will replace the polio vaccines used now,” he said after the launch of 2016 National Immunization Week (PIN) for polio at the Bio Farma complex in Bandung, West Java, on Tuesday.

Every year, Bio Farma produces at least 1.4 billion doses of polio vaccines to meet the global demand. “Around 20 million doses of the vaccines are to meet national demand,”Iskandar explained.

Along with the global target to eradicate polio by 2020, Iskandar said, Bio Farma had prepared various steps, including preparing inactivated polio vaccines (IPV).

The IPV, which is given as an injection, can be used alone or in conjunction with other vaccines.

”Around 100 people are involved in the production process of this injectable vaccine,” said Iskandar, adding that the company had been preparing IPV since 1992.

Polio was one of the main issues discussed at the 68th World Health Assembly in Geneva, Switzerland, in May 2015. In the meeting, Health Minister Nila Moeloke conveyed the government's commitment to support the world’s policies on the use of IPV to eradicate polio.

Indonesia’s immunization program, including the extending of polio vaccines to children aged 0-59 months, earned the country a polio-free certificate from the World Health Organization (WHO) on March 27, 2014.

Bio Farma corporate secretary M.Rahman Rustan said the company was currently supplying two thirds of total global polio vaccine need.

The WHO still has to wait for two countries in the Asia Region, namely Afghanistan and Pakistan, because in 2015, hundreds of children with polio were found in those countries,” he said.

Iskandar added that the production of IPV by Bio Farma, which he said was still trusted globally as a leading polio vaccine manufacturer, was an indicator of Indonesia's self-reliance. “It is part of the implementation of the so-called Nawacita, the nine development programs initiated by the government. We hope that we can make it.” (ebf)

- See more at: http://www.thejakartapost.com/news/2016/03/10/bio-farma-develops-injectable-polio-vaccine.html#sthash.pUtZxPAm.dpuf